A link between immune hyperactivation of T cells during HIV-1 infection and the virus protease?

被引:3
作者
Chiodi, F [1 ]
机构
[1] Karolinska Inst, Microbiol & Tumor Biol Ctr, S-17177 Stockholm, Sweden
关键词
T cell hyperactivation; protease inhibitors; HIV-1; protease; CD4 T cell decline; fitness;
D O I
10.1097/01.aids.0000216378.84313.b6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:769 / 771
页数:3
相关论文
共 18 条
[1]   Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication [J].
Alatrakchi, N ;
Duvivier, C ;
Costagliola, D ;
Samri, A ;
Marcelin, AG ;
Kamkamidze, G ;
Astriti, M ;
Agher, R ;
Calvez, V ;
Autran, B ;
Katlama, C .
AIDS, 2005, 19 (01) :25-33
[2]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[3]   Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults [J].
Barbour, JD ;
Wrin, T ;
Grant, RM ;
Martin, JN ;
Segal, MR ;
Petropoulos, CJ ;
Deeks, SG .
JOURNAL OF VIROLOGY, 2002, 76 (21) :11104-11112
[4]   Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection [J].
Barbour, JD ;
Hecht, FM ;
Wrin, T ;
Segal, MR ;
Ramstead, CA ;
Liegler, TJ ;
Busch, MP ;
Petropoulos, CJ ;
Hellmann, NS ;
Kahn, JO ;
Grant, RM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02) :251-256
[5]   High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy [J].
De Milito, A ;
Hejdeman, B ;
Albert, J ;
Aleman, S ;
Sönnerborg, A ;
Zazzi, M ;
Chiodi, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (14) :1379-1384
[6]   Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection [J].
De Milito, A ;
Nilsson, A ;
Titanji, K ;
Thorstensson, R ;
Reizenstein, E ;
Narita, M ;
Grutzmeier, S ;
Sönnerborg, A ;
Chiodi, F .
BLOOD, 2004, 103 (06) :2180-2186
[7]   Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection [J].
Deeks, SG ;
Hoh, R ;
Neilands, TB ;
Liegler, T ;
Aweeka, F ;
Petropoulos, CJ ;
Grant, RM ;
Martin, JN .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (09) :1537-1544
[8]   Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load [J].
Deeks, SG ;
Kitchen, CMR ;
Liu, L ;
Guo, H ;
Gascon, R ;
Narváez, AB ;
Hunt, P ;
Martin, JN ;
Kahn, JO ;
Levy, J ;
McGrath, MS ;
Hecht, FM .
BLOOD, 2004, 104 (04) :942-947
[9]   Shortened telomeres in the expanded CD28- CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis [J].
Effros, RB ;
Allsopp, R ;
Chiu, CP ;
Hausner, MA ;
Hirji, K ;
Wang, LL ;
Harley, CB ;
Villeponteau, B ;
West, MD ;
Giorgi, JV .
AIDS, 1996, 10 (08) :F17-F22
[10]   Perils at mucosal front lines for HIV and SIV and their hosts [J].
Haase, AT .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (10) :783-792